allicin has been researched along with transforming growth factor beta in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cao, Y; Huang, W; Ji, Z; Li, L; Liu, Y; Qi, H; Sun, H; Wang, Y; Wu, M | 1 |
Gao, W; Guo, RC; Jia, Q; Liang, ES; Lin, WW; Liu, DS; Wang, SL; Zhang, JD; Zhang, WD | 1 |
2 other study(ies) available for allicin and transforming growth factor beta
Article | Year |
---|---|
Allicin protects against myocardial apoptosis and fibrosis in streptozotocin-induced diabetic rats.
Topics: Animals; Apoptosis; Blood Glucose; Calcium; Cardiotonic Agents; Connective Tissue Growth Factor; Diabetes Mellitus, Experimental; Disulfides; Drug Evaluation, Preclinical; fas Receptor; Heart; Myocardium; Myocytes, Cardiac; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Streptozocin; Sulfinic Acids; Transforming Growth Factor beta | 2012 |
Effects of allicin on hyperhomocysteinemia-induced experimental vascular endothelial dysfunction.
Topics: Animals; Aorta; Disulfides; Endothelins; Endothelium, Vascular; Fibroblast Growth Factor 2; Gene Expression Regulation; Homocysteine; Hyperhomocysteinemia; Intercellular Adhesion Molecule-1; Male; Malondialdehyde; Nitric Oxide; Rats; Rats, Wistar; Sulfinic Acids; Superoxide Dismutase; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2013 |